K Adam Morrow
Overview
Explore the profile of K Adam Morrow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renema P, Pittet J, Brandon A, Leal Jr S, Gu S, Promer G, et al.
PLoS One
. 2024 Feb;
19(2):e0298816.
PMID: 38394060
Background: Bacterial pneumonia and sepsis are both common causes of end-organ dysfunction, especially in immunocompromised and critically ill patients. Pre-clinical data demonstrate that bacterial pneumonia and sepsis elicit the production...
2.
Lin M, Balczon R, Pittet J, Wagener B, Moser S, Morrow K, et al.
Am J Respir Crit Care Med
. 2018 Oct;
198(12):1575-1578.
PMID: 30280916
No abstract available.
3.
Balczon R, Morrow K, Zhou C, Edmonds B, Alexeyev M, Pittet J, et al.
FASEB J
. 2017 Mar;
31(7):2785-2796.
PMID: 28314768
Patients who recover from pneumonia subsequently have elevated rates of death after hospital discharge as a result of secondary organ damage, the causes of which are unknown. We used the...
4.
Morrow K, Frank D, Balczon R, Stevens T
Handb Exp Pharmacol
. 2017 Feb;
238:67-85.
PMID: 28181005
Exoenzyme Y (ExoY) was identified as a component of the Pseudomonas aeruginosa type 3 secretion system secretome in 1998. It is a common contributor to the arsenal of type 3...
5.
Morrow K, Das S, Meng E, Menezes M, Bailey S, Metge B, et al.
Oncotarget
. 2016 Feb;
7(14):17991-8005.
PMID: 26908451
The expression of the tumor suppressor Merlin is compromised in nervous system malignancies due to genomic aberrations. We demonstrated for the first time, that in breast cancer, Merlin protein expression...
6.
Morrow K, Ochoa C, Balczon R, Zhou C, Cauthen L, Alexeyev M, et al.
Am J Physiol Lung Cell Mol Physiol
. 2015 Dec;
310(4):L337-53.
PMID: 26637633
We tested the hypothesis that Pseudomonas aeruginosa type 3 secretion system effectors exoenzymes Y and U (ExoY and ExoU) induce release of a high-molecular-weight endothelial tau, causing transmissible cell injury...
7.
Stevens T, Ochoa C, Morrow K, Robson M, Prasain N, Zhou C, et al.
Am J Physiol Lung Cell Mol Physiol
. 2014 Apr;
306(10):L915-24.
PMID: 24705722
Exoenzyme Y (ExoY) is a Pseudomonas aeruginosa toxin that is introduced into host cells through the type 3 secretion system (T3SS). Once inside the host cell cytoplasm, ExoY generates cyclic...
8.
Morrow K, Shevde L
Biochim Biophys Acta
. 2012 Jul;
1826(2):400-6.
PMID: 22750751
Neurofibromatosis type 2 (NF2), characterized by tumors of the nervous system, is a result of functional loss of the NF2 gene. The NF2 gene encodes Merlin (moesin-ezrin-radixin-like protein), an ERM...
9.
Morrow K, Das S, Metge B, Ye K, Mulekar M, Tucker J, et al.
J Biol Chem
. 2011 Oct;
286(46):40376-85.
PMID: 21965655
Unlike malignancies of the nervous system, there have been no mutations identified in Merlin in breast cancer. As such, the role of the tumor suppressor, Merlin, has not been investigated...